Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X Syndrome.
Baldwin AG. et al, (2024), J Med Chem
Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε.
de Souza Gama FH. et al, (2024), J Med Chem, 67, 8609 - 8629
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Balıkçı E. et al, (2024), J Med Chem, 67, 7245 - 7259
Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases.
Henderson SH. et al, (2024), Eur J Med Chem, 269
Recent advances in the structural biology of tyrosine kinases.
Rygiel KA. and Elkins JM., (2023), Curr Opin Struct Biol, 82
Updated protein domain annotation of the PARP protein family sheds new light on biological function.
Suskiewicz MJ. et al, (2023), Nucleic Acids Res, 51, 8217 - 8236
Target 2035 - an update on private sector contributions.
Ackloo S. et al, (2023), RSC Med Chem, 14, 1002 - 1011
Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity.
Collins R. et al, (2022), J Med Chem, 65, 13705 - 13713
Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery.
Scott F. et al, (2022), Bioorg Med Chem Lett, 60
Chemical Probes for Understudied Kinases: Challenges and Opportunities.
Serafim RAM. et al, (2022), J Med Chem, 65, 1132 - 1170
Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.
Serafim RAM. et al, (2021), J Med Chem, 64, 13259 - 13278
Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors.
Henderson SH. et al, (2021), J Med Chem, 64, 11709 - 11728
Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2.
Berger B-T. et al, (2021), Cell Chem Biol, 28, 686 - 698.e7
Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family.
Quevedo CE. et al, (2020), Bioorg Med Chem, 28
Mining Public Domain Data to Develop Selective DYRK1A Inhibitors.
Henderson SH. et al, (2020), ACS Med Chem Lett, 11, 1620 - 1626
Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors.
Asquith CRM. et al, (2020), ChemMedChem, 15, 1200 - 1215
Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer.
Scott F. et al, (2020), Bioorg Med Chem Lett, 30
SGC-AAK1-1: A Chemical Probe Targeting AAK1 and BMP2K.
Wells C. et al, (2020), ACS Med Chem Lett, 11, 340 - 345
Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
Asquith CRM. et al, (2020), ChemMedChem, 15, 26 - 49